NOVONIX Ltd Files 6-K Report
Ticker: NVNXF · Form: 6-K · Filed: Apr 11, 2024 · CIK: 1859795
| Field | Detail |
|---|---|
| Company | Novonix LTD (NVNXF) |
| Form Type | 6-K |
| Filed Date | Apr 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, reporting
Related Tickers: NVX
TL;DR
NOVONIX filed a 6-K, check Exhibit 99.1 for updates.
AI Summary
NOVONIX Limited filed a Form 6-K on April 11, 2024, reporting information for the month of April 2024. The filing includes an exhibit index, with Exhibit 99.1 being the primary document. The company is incorporated in Australia and its principal executive offices are located in Brisbane.
Why It Matters
This filing provides an update on the company's reporting status and includes key exhibits that may contain material information for investors.
Risk Assessment
Risk Level: low — This is a routine filing that primarily serves to submit exhibits and does not contain significant new financial or operational disclosures.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- April 11, 2024 (date) — Filing Date
- April 2024 (date) — Reporting Period
- Brisbane, QLD 4000 Australia (location) — Principal Executive Office
- Exhibit 99.1 (document) — Included Exhibit
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that are required to disclose to the public information that it has made or is required to make public pursuant to the laws of its home country or jurisdiction, or a stock exchange on which it is traded, or that it has submitted or is required to submit to or is made or is required to be made by the company to its security holders.
What is the filing date of this 6-K report?
The filing date of this 6-K report is April 11, 2024.
What is the reporting period for this Form 6-K?
The reporting period for this Form 6-K is for the month of April, 2024.
Where are NOVONIX Limited's principal executive offices located?
NOVONIX Limited's principal executive offices are located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
What is listed in the Exhibit Index of this filing?
The Exhibit Index lists Exhibit 99.1 as the description for the document.
Filing Stats: 197 words · 1 min read · ~1 pages · Grade level 13 · Accepted 2024-04-11 16:41:32
Filing Documents
- nvx-6k-apr-24_04-10-pr_i.htm (6-K) — 18KB
- nvx-ex99_1.htm (EX-99.1) — 17KB
- img58969013_0.jpg (GRAPHIC) — 61KB
- 0000950170-24-043739.txt ( ) — 121KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: April 11, 2024